IL1B and neoplasm: Firstly, inhibiting IL1β prevents wnt activation of cancer stem cells in the bone, holding tumour cells in a dormant state in this organ [9] which might explain why IL1β inhibition is more effective at inhibiting metastatic outgrowth than reducing the growth of overt metastases.